Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.

Calcif Tissue Int. 2018 Nov;103(5):540-545. doi: 10.1007/s00223-018-0450-0. Epub  2018 Jun 27.

Reginster JY(1), Hattersley G(2), Williams GC(3), Hu MY(3), Fitzpatrick LA(3), Lewiecki EM(4).

DOI: 10.1007/s00223-018-0450-0  -PMCID: PMC6182596 PMID: 29951742

https://www.ncbi.nlm.nih.gov/pubmed/29951742

 

Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen